Table 1. Baseline characteristic of the 142 patients with thymoma according to Masaoka stage, WHO histology and MG.
| Subgroups | Basic information | Underlying disease | Life style | Clinical symptom | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender (female) | Age (years) | HT | CAD | DM | Smoking | Drinking | Chest pain/tight | Cough | Fever | Edema | ||||
| All (n=142) | 66 | 51.35±14.30 | 19 | 1 | 7 | 52 | 35 | 32 | 30 | 3 | 4 | |||
| Masaoka (n=139) | ||||||||||||||
| I (n=48) | 25 | 51.60±14.08 | 6 | 1 | 3 | 16 | 12 | 6 | 12 | 1 | 0 | |||
| II (n=32) | 16 | 52.97±15.31 | 5 | 0 | 2 | 9 | 7 | 7 | 4 | 0 | 0 | |||
| III (n=25) | 15 | 49.03±14.37 | 4 | 0 | 2 | 16 | 8 | 14 | 6 | 0 | 0 | |||
| IV (n=24) | 9 | 52.00±14.39 | 4 | 0 | 0 | 10 | 7 | 5 | 7 | 1 | 3 | |||
| P value | 0.632 | 0.715 | 0.581 | 0.544 | 0.433 | 0.436 | 0.928 | 0.032 | 0.369 | 0.407 | 0.012 | |||
| WHO histology (n=107) | ||||||||||||||
| A (n=15) | 7 | 58.73±9.92 | 1 | 0 | 1 | 4 | 4 | 0 | 7 | 1 | 0 | |||
| AB (n=29) | 13 | 53.24±12.11 | 5 | 1 | 3 | 15 | 12 | 4 | 5 | 0 | 0 | |||
| B1 (n=24) | 16 | 48.17±15.47 | 3 | 0 | 1 | 4 | 2 | 5 | 3 | 1 | 0 | |||
| B2 (n=10) | 5 | 49.30±12.13 | 1 | 0 | 1 | 3 | 1 | 0 | 0 | 0 | 1 | |||
| B3 (n=11) | 5 | 46.00±15.01 | 2 | 0 | 0 | 4 | 3 | 4 | 5 | 0 | 0 | |||
| C (n=18) | 6 | 56.72±13.02 | 3 | 0 | 0 | 7 | 2 | 9 | 4 | 0 | 2 | |||
| P value | 0.409 | 0.056 | 0.915 | 0.756 | 0.444 | 0.165 | 0.084 | 0.001 | 0.014 | 0.518 | 0.14 | |||
| Patients with MG or not (n=142) | ||||||||||||||
| Yes (n=42) | 16 | 46.21±15.57 | 2 | 0 | 3 | 16 | 11 | 1 | 2 | 0 | 0 | |||
| No (n=100) | 50 | 53.50±13.23 | 17 | 1 | 4 | 36 | 24 | 31 | 28 | 3 | 4 | |||
| P value | 0.194 | 0.005 | 0.051 | 1 | 0.715 | 0.813 | 0.782 | <0.001 | 0.002 | 0.555 | 0.448 | |||
WHO, World Health Organization; MG, myasthenia gravis.